miR-2861 acts as a tumor suppressor via targeting EGFR/AKT2/CCND1 pathway in cervical cancer induced by human papillomavirus virus 16 E6
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
miR-2861 acts as a tumor suppressor via targeting EGFR/AKT2/CCND1 pathway in cervical cancer induced by human papillomavirus virus 16 E6
Authors
Keywords
-
Journal
Scientific Reports
Volume 6, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-07-01
DOI
10.1038/srep28968
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Role of PI3K, mTOR and Akt2 signalling in hepatic tumorigenesis via the control of PKM2 expression
- (2013) Ivan Nemazanyy et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Activation of the EGFR/Akt/NF-κB/cyclinD1 survival signaling pathway in human cholesteatoma epithelium
- (2013) Wei Liu et al. EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY
- MicroRNA-155 Is Required for Effector CD8+ T Cell Responses to Virus Infection and Cancer
- (2013) Jan C. Dudda et al. IMMUNITY
- Inhibition of the PI3K/AKT pathway potentiates cytotoxicity of EGFR kinase inhibitors in triple-negative breast cancer cells
- (2013) Yong Weon Yi et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- The p53 Transcription Factor Modulates Microglia Behavior through MicroRNA-Dependent Regulation of c-Maf
- (2013) W. Su et al. JOURNAL OF IMMUNOLOGY
- Upregulation of miR-2861 and miR-451 expression in papillary thyroid carcinoma with lymph node metastasis
- (2013) Zhihong Wang et al. MEDICAL ONCOLOGY
- EGFR-mediated Akt and MAPKs signal pathways play a crucial role in patulin-induced cell proliferation in primary murine keratinocytes via modulation ofCyclin D1andCOX-2expression
- (2013) Shamshad Alam et al. MOLECULAR CARCINOGENESIS
- Cyclin D1, EGFR, and Akt/mTOR pathway
- (2013) D. Dionysopoulos et al. STRAHLENTHERAPIE UND ONKOLOGIE
- The p53 miRNA interactome and its potential role in the cancer clinic
- (2013) Jonathan Krell et al. Epigenomics
- Expression of microRNAs in basal cell carcinoma
- (2012) M. Sand et al. BRITISH JOURNAL OF DERMATOLOGY
- Causes and Consequences of MicroRNA Dysregulation
- (2012) Marilena V. Iorio et al. CANCER JOURNAL
- Dysregulation of global microRNA expression in splenic marginal zone lymphoma and influence of chronic hepatitis C virus infection
- (2012) J Peveling-Oberhag et al. LEUKEMIA
- Suppressed miR-424 expression via upregulation of target gene Chk1 contributes to the progression of cervical cancer
- (2012) J Xu et al. ONCOGENE
- Updating the Natural History of Human Papillomavirus and Anogenital Cancers
- (2012) Anna-Barbara Moscicki et al. VACCINE
- miR-375 Is Down-Regulated in Squamous Cervical Cancer and Inhibits Cell Migration and Invasion via Targeting Transcription Factor SP1
- (2011) Fenfen Wang et al. AMERICAN JOURNAL OF PATHOLOGY
- Epidermal growth factor receptor as a biomarker for cervical cancer
- (2011) T. Soonthornthum et al. ANNALS OF ONCOLOGY
- Regulation of cellular miRNA expression by human papillomaviruses
- (2011) Zhi-Ming Zheng et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- A Runx2/miR-3960/miR-2861 Regulatory Feedback Loop during Mouse Osteoblast Differentiation
- (2011) Rong Hu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Progressive miRNA expression profiles in cervical carcinogenesis and identification of HPV-related target genes for miR-29
- (2011) Yang Li et al. JOURNAL OF PATHOLOGY
- Human papillomavirus type 16 E6 induces cervical cancer cell migration through the p53/microRNA-23b/urokinase-type plasminogen activator pathway
- (2011) C L Au Yeung et al. ONCOGENE
- Ultra-high throughput sequencing-based small RNA discovery and discrete statistical biomarker analysis in a collection of cervical tumours and matched controls
- (2010) Daniela Witten et al. BMC BIOLOGY
- Increased expression of Akt2 and activity of PI3K and cell proliferation with the ascending of tumor grade of human gliomas
- (2010) Guangxiu Wang et al. CLINICAL NEUROLOGY AND NEUROSURGERY
- Reduced miR-34a Expression in Normal Cervical Tissues and Cervical Lesions With High-Risk Human Papillomavirus Infection
- (2010) Baohua Li et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Human Papillomaviruses Modulate Expression of MicroRNA 203 upon Epithelial Differentiation to Control Levels of p63 Proteins
- (2010) M. Melar-New et al. JOURNAL OF VIROLOGY
- Mammalian microRNAs predominantly act to decrease target mRNA levels
- (2010) Huili Guo et al. NATURE
- Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments
- (2010) Hans-Ulrich Bernard et al. VIROLOGY
- MicroRNAs: Predictors and modifiers of chemo- and radiotherapy in different tumour types
- (2009) Richard Hummel et al. EUROPEAN JOURNAL OF CANCER
- miRNA control of tumor cell invasion and metastasis
- (2009) Somesh Baranwal et al. INTERNATIONAL JOURNAL OF CANCER
- A novel microRNA targeting HDAC5 regulates osteoblast differentiation in mice and contributes to primary osteoporosis in humans
- (2009) Hui Li et al. JOURNAL OF CLINICAL INVESTIGATION
- Causes and consequences of microRNA dysregulation in cancer
- (2009) Carlo M. Croce NATURE REVIEWS GENETICS
- Oncogenic HPV infection interrupts the expression of tumor-suppressive miR-34a through viral oncoprotein E6
- (2009) X. Wang et al. RNA
- The impact of microRNAs on protein output
- (2008) Daehyun Baek et al. NATURE
- Widespread changes in protein synthesis induced by microRNAs
- (2008) Matthias Selbach et al. NATURE
- Human papillomaviruses, cervical cancer and cell polarity
- (2008) M Thomas et al. ONCOGENE
- Aberrant Expression of Oncogenic and Tumor-Suppressive MicroRNAs in Cervical Cancer Is Required for Cancer Cell Growth
- (2008) Xiaohong Wang et al. PLoS One
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started